SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway

Figure 1

NMT1 was upregulated in GC tissues and might be a potential biomarker of GC diagnosis. (a) The differentially expressed NMT1 between GC (n = 408) and normal (n = 211) tissue samples was analyzed by GEPIA (http://gepia.cancer-pku.cn/). (b) The overall survival of GC patients with high (n = 605) or low (n = 270) NMT1 expression was analyzed by GEPIA,  = 1.1e-05. ^∗ < 0.05 vs. Normal tissues. NMT1, N-myristoyltransferase 1; GC, gastric cancer; GEPIA, gene expression profiling interactive analysis.

(a)

(b)